Medsafe - Latest News [Page 2]
Medsafe requests Ritalin SR be made available
Thursday, 27 September 2007, 2:03 pm | Medsafe
Following Medsafe concerns about the safety profile of the medicine Rubifen SR, Pharmac has announced it will make Ritalin SR available to people who experience serious side-effects following use of Rubifen SR, the subsidised brand of slow-release methylphenidate. More >>
Prexige 200mg and 400mg tablets to be withdrawn
Tuesday, 21 August 2007, 11:25 am | Medsafe
Consents allowing the supply of 200mg and 400mg tablets of the COX-2 anti-inflammatory medicine Prexige have been revoked in New Zealand by the Medicines and Medical Devices Safety Authority, Medsafe. More >>
New use of cancer therapy can halve risk of death
Friday, 10 November 2006, 3:30 pm | Medsafe
MedSafe registration approval has been given for a new use of a cancer treatment for patients diagnosed with indolent non-Hodgkin’s lymphoma (NHL). More >>
Fees increase for the evaluation, approval of meds
Friday, 21 July 2006, 4:19 pm | Medsafe
The Ministry of Health's medicines regulatory arm, Medsafe has announced fees for the evaluation and registration of medicines will go up next month - many for the first time in 15 years or more - because of increased operating costs and changes ... More >>
ReNu MoistureLoc Not Approved For Use In NZ
Wednesday, 12 April 2006, 10:44 am | Medsafe
ReNu MoistureLoc, a Bausch & Lomb product marketed in the United States is not approved for use in New Zealand. More >>
Medsafe Removes Restrictions On Vaxigrip Vaccine
Friday, 6 May 2005, 10:56 am | Medsafe
The New Zealand Medicines and Medical Devices Safety Authority (Medsafe) today removed restrictions on influenza vaccine Vaxigrip. More >>